Lantern Pharma Inc. (LTRN)
LTRN trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$0.7107
-3.57% on the day
Market cap
$10.6M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | LTRN on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2020 |
| SEC CIK | 0001763950 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | TX |
Financials
Not reported in SEC XBRL data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | 424B5 | 2026-09-30 |
| Latest annual report | 10-K/A | 2026-04-30 |
| Latest quarterly / interim | 10-Q | 2026-08-14 |
| Latest current report | 8-K | 2026-10-01 |
| Latest proxy | PRE 14A | 2026-10-08 |
Source: SEC EDGAR submissions feed, 260 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| BFRG | Bullfrog AI Holdings Inc. | $0.5689 | -2.55% | $10.5M |
| BLRX | BioLineRx Ltd. | $2.17 | 0.00% | $10.8M |
| BIVI | BioVie Inc. | $1.20 | -9.09% | $10.4M |
| PHIO | Phio Pharmaceuticals Corp. | $0.9345 | +1.36% | $10.9M |
| KPRX | Kiora Pharmaceuticals Inc. | $2.47 | -3.52% | $10.9M |
| GDTC | CytoMed Therapeutics Limited | $0.8700 | +7.22% | $10.3M |
| ENSC | Ensysce Biosciences Inc. | $0.5725 | +2.99% | $11.1M |
| ACTU | Actuate Therapeutics Inc. | $0.4663 | -27.56% | $11.2M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier